These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1333292)

  • 1. Hematuria in bone marrow transplant patients.
    Sabau DM
    J Am Soc Nephrol; 1992 Oct; 3(4):916-20. PubMed ID: 1333292
    [No Abstract]   [Full Text] [Related]  

  • 2. Chryseobacterium indologenes bacteremia in a bone marrow transplant recipient with chronic graft-versus-host disease.
    Lin JT; Wang WS; Yen CC; Liu JH; Chiou TJ; Yang MH; Chao TC; Chen PM
    Scand J Infect Dis; 2003; 35(11-12):882-3. PubMed ID: 14723368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total body irradiation and high-dose cyclophosphamide, BCNU and VP-16 (CBV) as a new preparatory regimen for allogeneic bone marrow transplantation in patients with advanced hematologic malignancies.
    Wu DP; Milpied N; Moreau P; Mechinaud-Lacroix F; Mahe B; Le Tortorec S; Rapp MJ; Bourdin S; Mahe JM; Harousseau JL
    Bone Marrow Transplant; 1994 Nov; 14(5):751-7. PubMed ID: 7889008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemorrhagic cystitis due to adenovirus type 11 after allogeneic bone marrow transplantation in two patients with aplastic anemia.
    Itoh T; Baba M; Nunokawa H; Sakurai T; Morimoto K; Kubo Y; Hatta Y; Amaki I; Yamamoto T
    Nihon Ketsueki Gakkai Zasshi; 1987 Sep; 50(6):1134-41. PubMed ID: 2825458
    [No Abstract]   [Full Text] [Related]  

  • 5. Unrelated allogeneic bone marrow transplantation using high-dose busulfan and cyclophosphamide (BU-CY) for the preparative regimen.
    Sahebi F; Copelan E; Crilley P; Bolwell B; Avalos B; Klein J; Territo M; Gajewski J
    Bone Marrow Transplant; 1996 May; 17(5):685-9. PubMed ID: 8733682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemorrhagic cystitis due to adenovirus infection following bone marrow transplantation.
    Londergan TA; Walzak MP
    J Urol; 1994 Apr; 151(4):1013-4. PubMed ID: 8126773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laryngeal stenosis associated with chronic graft-versus-host disease following unrelated bone marrow transplantation.
    Hirokawa M; Kume M; Wu T; Ishikawa K; Sawada KI
    Bone Marrow Transplant; 2006 Sep; 38(5):387-8. PubMed ID: 16862163
    [No Abstract]   [Full Text] [Related]  

  • 8. Non-supralethal mitobronitol/cytarabine/cyclophosphamide conditioning without irradiation before bone marrow transplantation for accelerated chronic granulocytic leukemia: apparent absence of acute graft-versus-host disease.
    Kelemen E; Jakab K; Váradi G; Jánossa M; Földi J; Dénes R
    Leukemia; 1993 Jul; 7(7):939-45. PubMed ID: 8321045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus type II and cyclophosphamide hemorrhagic cystitis.
    Royal JE; Hope TO; Seeler RA
    IMJ Ill Med J; 1976 Aug; 150(2):133-5. PubMed ID: 8373
    [No Abstract]   [Full Text] [Related]  

  • 10. Allogeneic marrow transplantation in patients with chronic myeloid leukemia in chronic phase following preparation with busulfan and cyclophosphamide.
    Galimberti M; Polchi P; Lucarelli G; Angelucci E; Baronciani D; Giardini C; Gaziev D; Erer B; Ripalti M; Rapa S
    Bone Marrow Transplant; 1994 Feb; 13(2):197-201. PubMed ID: 8205089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemorrhagic cystitis in bone marrow transplantation patients: possible increased risk associated with prior busulphan therapy.
    Thomas AE; Patterson J; Prentice HG; Brenner MK; Ganczakowski M; Hancock JF; Pattinson JK; Blacklock HA; Hopewell JP
    Bone Marrow Transplant; 1987 Apr; 1(4):347-55. PubMed ID: 3139113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A retrospective single centre study of the outcome of five different therapy approaches in 48 patients with relapse of chronic myelogenous leukemia after allogeneic bone marrow transplantation.
    Elmaagacli AH; Beelen DW; Schaefer UW
    Bone Marrow Transplant; 1997 Dec; 20(12):1045-55. PubMed ID: 9466277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and cost of hyperhydration for the prevention of hemorrhagic cystitis in bone marrow transplant recipients.
    Ballen KK; Becker P; Levebvre K; Emmons R; Lee K; Levy W; Stewart FM; Quesenberry P; Lowry P
    Oncology; 1999 Nov; 57(4):287-92. PubMed ID: 10575313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The management of chronic myeloid leukaemia--a case history.
    Sureda A; Hernández-Bronchud M
    Ann Oncol; 1997 Jan; 8(1):91-6. PubMed ID: 9093713
    [No Abstract]   [Full Text] [Related]  

  • 15. Hemorrhagic cystitis associated with adenovirus infection in bone marrow transplantation.
    Ambinder RF; Burns W; Forman M; Charache P; Arthur R; Beschorner W; Santos G; Saral R
    Arch Intern Med; 1986 Jul; 146(7):1400-1. PubMed ID: 3013110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haematocolpos following allogenic bone marrow transplantation for chronic myeloid leukaemia.
    Jain SP; Henry RJ
    BJOG; 2001 Dec; 108(12):1309-10. PubMed ID: 11843399
    [No Abstract]   [Full Text] [Related]  

  • 17. Permanent alopecia following chemotherapy and bone marrow transplantation.
    Tran D; Sinclair RD; Schwarer AP; Chow CW
    Australas J Dermatol; 2000 May; 41(2):106-8. PubMed ID: 10812705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Allogeneic bone marrow transplantation in myeloid leukemia: chemical conditioning, clinical course and results].
    Glejzer O; Sedzimirska M; Tomaszewska-Toporska B; Tomeczko J; Kołodziej J; Pacuszko T; Was A; Bocheńska J; Jaźwiec B; Klimczak A
    Acta Haematol Pol; 1992; 23(2 Suppl 1):49-59. PubMed ID: 1488872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemia.
    Hambach L; Eder M; Dammann E; Battmer K; Stucki A; Heil G; Ganser A; Hertenstein B
    Bone Marrow Transplant; 2001 Oct; 28(7):705-7. PubMed ID: 11704795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5q- in a case of chronic myelogenous leukemia relapsed after allogeneic bone marrow transplantation.
    Soligo D; Romitti L; Bertolli V; Della Volpe A; Annaloro C; Lambertenghi Deliliers G
    Haematologica; 1995; 80(5):437-9. PubMed ID: 8566886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.